1-3 of 3
Deidre Deam, RN
Close
Sort by
Journal Articles

Phase I Trial of Flavopiridol In Relapsed Myeloma: Brief Response In t(4;14) with Significant Neutropenia

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Seungsoo Lee, MS, Mitch A. Phelps, PhD, Don M Benson, Jr, MD, PhD, Eric H. Kraut, MD, William J Hicks, MD, Deidre Deam, RN, Amy J Johnson, PhD, Sherif Farag, MD, PhD, FRACP, FRCPA, Jeffrey A. Jones, MD, MPH, John C. Byrd, MD
Journal: Blood
Blood (2010) 116 (21): 1933.
https://doi.org/10.1182/blood.V116.21.1933.1933
Published: 2010
Journal Articles

Phase 1 Trial of Flavopiridol and Lenalidomide In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL)

Kristie A. Blum, MD, Jeffrey A. Jones, MD, MPH, Leslie Andritsos, MD, Joseph M. Flynn, DO, MPH, Deidre Deam, RN, Nyla A. Heerema, PhD, Mitchell Phelps, PhD, Amy J Johnson, PhD, Michael R. Grever, M.D., John C. Byrd, MD
Journal: Blood
Blood (2010) 116 (21): 2472.
https://doi.org/10.1182/blood.V116.21.2472.2472
Published: 2010
Journal Articles

Flavopiridol Can Be Safely Administered Using a Pharmacologically Derived Schedule and Demonstrates Activity In Relapsed and Refractory Non-Hodgkin's Lymphoma.

Jeffrey A. Jones, MD, MPH, Leslie Andritsos, MD, Robert Baiocchi, MD, PhD, Don M Benson, Jr., MD, PhD, Kristie A. Blum, MD, Beth Christian, MD, Deidre Deam, RN, Joseph M. Flynn, DO, MPH, Amy J. Johnson, PhD, Mitch A. Phelps, PhD, Pierluigi Porcu, MD, John C. Byrd, MD, Michael R. Grever, M.D.
Journal: Blood
Blood (2010) 116 (21): 2834.
https://doi.org/10.1182/blood.V116.21.2834.2834
Published: 2010